Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Fexinidazole

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    EMA gives positive opinion to Fexinidazole as first oral treatment of rhodesiense
    EMA gives positive opinion to Fexinidazole as first oral treatment of rhodesiense

    15 Dec 2023

    // PRESS RELEASE

    https://www.sanofi.com/en/media-room/press-releases/2023/2023-12-15-06-00-00-2796815

    PRESS RELEASE
    15 Dec 2023
    Share Share
    Sanofi gets positive EMA opinion for sleeping sickness treatment
    Sanofi gets positive EMA opinion for sleeping sickness treatment

    15 Dec 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-gets-positive-ema-opinion-sleeping-sickness-treatment-2023-12-15/

    REUTERS
    15 Dec 2023
    Share Share
    USFDA approves fexinidazole as first all-oral treatment for sleeping sickness
    USFDA approves fexinidazole as first all-oral treatment for sleeping sickness

    19 Jul 2021

    // CONTAGIONLIVE

    https://www.contagionlive.com/view/fda-approves-sleeping-sickness-therapy

    CONTAGIONLIVE
    19 Jul 2021
    Share Share
    CHMP recommends first oral-only treatment for sleeping sickness
    CHMP recommends first oral-only treatment for sleeping sickness

    18 Nov 2018

    // EMA

    https://www.ema.europa.eu/en/news/chmp-recommends-first-oral-only-treatment-sleeping-sickness

    EMA
    18 Nov 2018
    Share Share
    Meeting highlights from Committee for Medicinal Products for Human Use 12-15 Nov, 18
    Meeting highlights from Committee for Medicinal Products for Human Use 12-15 Nov, 18

    17 Nov 2018

    // EMA

    https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-12-15-november-2018

    EMA
    17 Nov 2018
    Share Share
    Sanofi teams with non-profit on a landmark new drug for sleeping sickness
    Sanofi teams with non-profit on a landmark new drug for sleeping sickness

    16 Nov 2018

    // John Carroll ENDPTS

    https://endpts.com/sanofi-teams-with-non-profit-on-a-landmark-new-drug-for-sleeping-sickness/

    John Carroll ENDPTS
    16 Nov 2018
    Share Share